9/11/19 13:32 | 9/9/19 | PGNX | Health | Drug | Pharmaceutical Preparations | Velan Capital, L.P. | GA | TH | See Expl | P | 360 | 4.99 | 0 | 72 | 1 | 8,012 | D | | | | | | | | | | | | | | |
9/9/19 18:14 | 9/5/19 | PGNX | Health | Drug | Pharmaceutical Preparations | Lte Partners, LLC | NY | TH | See Expl | P.m | 307 | 4.73 | 0 | 65 | 3 | 1,950 | D | | | | | | | | | | | | | | |
9/5/19 16:37 | 9/3/19 | PGNX | Health | Drug | Pharmaceutical Preparations | Velan Capital, L.P. | GA | TH | See Expl | P.m | 2,317 | 4.45 | 0 | 521 | 7 | 7,940 | D | | | | | | | | | | | | | | |
8/27/19 15:45 | 8/23/19 | PGNX | Health | Drug | Pharmaceutical Preparations | Velan Capital, L.P. | GA | TH | See Expl | P.m | 879 | 4.31 | 0 | 204 | 3 | 7,419 | D | | | | | | | | | | | | | | |
4/22/16 17:09 | 12/1/10 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | D | | P.a | 25 | 4.90 | 4 | 5 | 1 | 910 | D | 34 | -17 | -21 | 32 | 18 | 19 | 9 | -1 | 0 | -1 | -14 | 12 | 0 | |
7/23/14 10:42 | 7/16/14 | PGNX | Health | Drug | Pharmaceutical Preparations | Broadfin Healthcare Master Fund Ltd | E9 | T | | P.m | 7,476 | 4.60 | 8 | 1,625 | 22 | 8,951 | D | -54 | -22 | -30 | 25 | 26 | 6 | 15 | 8 | 3 | 3 | 6 | -1 | 23 | 78 |
3/28/13 09:24 | 3/27/13 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 5.32 | 3 | 1 | 0 | 161 | D | -12 | -43 | 61 | 80 | 94 | 57 | 20 | 6 | 0 | -7 | -11 | -18 | -4 | -26 |
2/28/13 17:24 | 2/27/13 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 2.72 | 0 | 1 | 1 | 160 | D | -52 | -73 | -36 | 19 | -19 | -8 | -6 | -2 | 6 | 18 | 102 | 52 | 113 | 84 |
1/23/13 09:59 | 1/22/13 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 2.82 | 1 | 1 | 1 | 159 | D | -53 | -70 | -73 | -13 | 20 | -5 | -15 | -8 | 4 | 5 | -4 | 70 | 113 | 142 |
12/26/12 13:05 | 12/26/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 3.01 | 1 | 1 | 1 | 158 | D | -39 | -66 | -66 | -10 | 97 | 35 | 37 | 4 | -3 | 9 | -3 | 80 | 47 | 83 |
11/30/12 12:07 | 11/28/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 2.13 | 1 | 2 | 1 | 157 | D | -54 | -59 | -75 | -46 | -26 | 14 | 10 | 0 | 4 | 3 | 32 | 26 | 81 | 127 |
11/20/12 13:41 | 11/19/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 23 | 1.96 | 1 | 12 | 8 | 155 | D | -54 | -67 | -73 | -51 | -24 | -30 | 3 | 29 | 10 | 6 | 40 | 33 | 91 | 90 |
11/19/12 13:50 | 11/16/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 91 | 1.82 | 1 | 50 | 53 | 143 | D | -59 | -70 | -76 | -58 | -33 | -36 | -31 | 11 | 10 | 22 | 30 | 50 | 116 | 102 |
11/16/12 13:54 | 11/15/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 82 | 1.69 | 0 | 49 | 109 | 94 | D | -63 | -72 | -80 | -60 | -36 | -41 | -42 | 12 | 9 | 37 | 38 | 71 | 145 | 126 |
10/25/12 11:34 | 10/24/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 2.96 | 1 | 1 | 3 | 45 | D | -40 | -55 | -73 | -73 | -22 | 4 | -4 | -11 | 0 | -5 | -25 | 2 | 59 | 41 |
9/27/12 15:14 | 9/26/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 3.32 | 1 | 1 | 2 | 44 | D | -40 | -53 | -70 | -67 | -28 | -14 | -16 | -9 | -1 | -12 | -4 | -9 | 78 | 66 |
8/23/12 09:44 | 8/22/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 4.23 | 3 | 1 | 2 | 43 | D | 5 | -32 | -58 | -47 | -58 | -9 | -1 | 0 | 0 | 1 | -20 | -45 | -35 | 24 |
7/26/12 11:42 | 7/25/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 10.04 | 2 | 0 | 1 | 42 | D | 125 | 63 | 7 | -5 | 28 | -1 | 0 | 0 | 5 | -53 | -59 | -71 | -71 | -40 |
6/29/12 09:15 | 6/27/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 9.27 | 2 | 0 | 1 | 41 | D | 67 | 27 | 6 | -8 | 16 | 8 | 7 | 1 | 7 | 13 | -41 | -67 | -67 | -51 |
5/24/12 12:38 | 5/23/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 7.81 | 1 | 0 | 1 | 41 | D | 80 | 12 | 37 | -21 | -19 | -23 | -10 | 5 | 2 | 9 | 11 | -47 | -71 | -46 |
4/27/12 09:23 | 4/25/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 4 | 10.07 | 1 | 0 | 1 | 41 | D | 68 | 48 | 69 | 16 | 15 | 11 | 12 | 2 | 3 | -5 | -22 | -2 | -73 | -57 |
3/29/12 15:12 | 3/28/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 10.13 | 1 | 0 | 1 | 40 | D | 89 | 57 | 55 | 14 | 4 | 10 | 0 | 5 | 0 | 0 | 12 | -8 | -70 | -46 |
2/23/12 09:28 | 2/22/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 9.41 | 1 | 0 | 1 | 40 | D | 104 | 67 | 54 | 56 | 6 | -4 | 0 | -2 | 5 | 2 | -1 | -17 | -56 | -73 |
1/26/12 10:05 | 1/25/12 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 9.53 | 1 | 0 | 1 | 40 | D | 107 | 57 | 53 | 45 | 28 | 13 | 11 | 2 | -2 | 4 | 6 | 12 | 7 | -69 |
1/12/12 13:16 | 10/26/11 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P.m | 7 | 7.51 | 3 | 1 | 2 | 39 | D | 102 | 58 | 16 | 43 | 60 | 5 | 4 | 4 | 0 | 6 | 7 | 10 | 14 | -61 |
9/28/11 16:55 | 9/28/11 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 6.39 | 1 | 1 | 1 | 37 | D | 15 | 27 | 1 | -15 | 8 | 12 | 12 | 12 | -1 | 7 | 13 | 45 | 64 | -44 |
8/25/11 09:31 | 8/24/11 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 6.08 | 1 | 1 | 2 | 36 | D | 13 | 50 | 9 | -17 | -18 | 17 | -3 | -5 | -3 | 1 | -4 | -11 | 63 | -32 |
7/28/11 17:06 | 7/27/11 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 6.12 | 1 | 1 | 2 | 36 | D | 9 | 29 | -10 | -23 | -17 | -27 | -20 | -14 | -4 | 4 | 5 | 12 | 65 | 88 |
6/24/11 10:07 | 6/22/11 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 7.08 | 1 | 0 | 2 | 32 | D | 48 | 29 | 40 | 13 | -20 | -11 | -4 | -2 | 0 | 4 | -7 | -17 | 28 | 27 |
5/26/11 15:15 | 5/25/11 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 7.13 | 1 | 0 | 2 | 31 | D | 43 | 52 | 56 | 32 | 3 | 0 | -9 | -2 | 6 | 6 | -7 | -17 | -26 | 9 |
4/27/11 16:05 | 4/27/11 | PGNX | Health | Drug | Pharmaceutical Preparations | Baker Mark Robert | NY | DO | CEO | P | 3 | 7.24 | 1 | 0 | 2 | 31 | D | 28 | 16 | 49 | 21 | 28 | 18 | -2 | -1 | 1 | 5 | 2 | -15 | -11 | 46 |
12/1/10 16:12 | 12/1/10 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | DO | CEO,CSO | P | 25 | 4.90 | 1 | 5 | 1 | 854 | D | -49 | 23 | -10 | 18 | -6 | 3 | 4 | -3 | 0 | -2 | 9 | 15 | 59 | 12 |
11/2/10 11:54 | 11/1/10 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | DO | CEO,CSO | P | 24 | 4.76 | 1 | 5 | 1 | 849 | D | -49 | 15 | -27 | -1 | 5 | -8 | -2 | 2 | 1 | 0 | 3 | 19 | 60 | 36 |
10/4/10 17:37 | 10/4/10 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | DO | CEO,CSO | P | 25 | 4.99 | 1 | 5 | 1 | 844 | D | -64 | 1 | -9 | -7 | 20 | 13 | -1 | 0 | 4 | 1 | -2 | 10 | 27 | 16 |
9/2/10 10:39 | 9/1/10 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | DO | CEO,CSO | P | 21 | 4.10 | 1 | 5 | 1 | 839 | D | -71 | -20 | -9 | -25 | -2 | -14 | 3 | 2 | 4 | 6 | 22 | 19 | 39 | 49 |
8/2/10 17:13 | 8/2/10 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | DO | CEO,CSO | P | 24 | 4.75 | 1 | 5 | 1 | 834 | D | -72 | -20 | 2 | -29 | -24 | -14 | 7 | 2 | 5 | 5 | -14 | 0 | 21 | 18 |
7/19/10 15:01 | 7/16/10 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | DO | CEO,CSO | P | 25 | 4.99 | 1 | 5 | 1 | 829 | D | -71 | -10 | -2 | -17 | -8 | -16 | -14 | -16 | 4 | -8 | -3 | 17 | 32 | 58 |
6/2/10 14:47 | 6/1/10 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | DO | CEO,CSO | P | 25 | 4.99 | 1 | 5 | 1 | 824 | D | -70 | -5 | 24 | 2 | -16 | -11 | 5 | 0 | 8 | 1 | 12 | -18 | 1 | 70 |
5/21/10 13:29 | 5/20/10 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | DO | CEO,CSO | P | 25 | 4.93 | 1 | 5 | 1 | 819 | D | -66 | -14 | 12 | -3 | -14 | -28 | -15 | -16 | -5 | 9 | 28 | -12 | -5 | 75 |
10/19/09 10:58 | 10/16/09 | PGNX | Health | Drug | Pharmaceutical Preparations | Maddon Paul J | NY | OT | CEO,CSO | P | 90 | 4.88 | 1 | 19 | 2 | 805 | D | -80 | -56 | -7 | -7 | -11 | -14 | -7 | 1 | 4 | -7 | -13 | -1 | 21 | 11 |